3Hans CP,Weisenburger DD,Greiner TC,et al.Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.Blood,2004,103(1);275-282.
4Bureau F,Vanderplasschen A,Jaspar F,et al.Constitutive nuclear factor-kappaB activity preserves homeostasis of quiescent mature lymphocytes and granulocytes by controlling the expression of distinct Bcl-2 family proteins.Blood,2002,99(10):3683-3691.
5Iqbal J,Sanger WG,Horsman DE,et al.BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma.Am J Pathol,2004,165(1):159-166.
6Swerdlow SH,Campo E,Harris NL,et al.World Health Organization classification of tumors.WHO classification of tumors of haematopoietic and lymphoid tissues.Lyon:IARC Press,2008.
7Moskowitz CH,Zelenetz AD,Kewalramani T,et al.Cell of origin,germinal center versus nongerminal center,determined by immunohistochemistry on tissue microarray,does not correlate with outcome in patients with relapsed and refractory DLBCL.Blood,2005,106(10):3383-3385.
8Colomo L,Lopez-Guillermo A,Perales M,et al.Clinical impact of the differentiation profile assesed by immunonphenotyping in patients with diffuse large B-cell lymphoma.Blood,2003,101(1):78-82.
9Barrans SL,Evans PA,O′Connor SJ,et al.The t(14;18) is associated with germinal center-derived diffuse large B-cell lymphoma and is a strong predictor of outcome.Clin Cancer Res,2003,9(6);2133-2139.
10Monni O,Joensuu H,Fanssila K,et al.DNA copy number changes in diffuse large B-cell lymphoma--comparative genomic hybridization study.Blood,1996,87(12):5269-5278.
